ImmunityBio

About ImmunityBio

ImmunityBio is a late-stage immunotherapy startup that is developing treatments to drive immunogenic pathways in the fight against cancer.

Explore similar firms in the Healthcare & Medical

Email Format

{first_name}.{last_name}@immunitybio.com — 54.5%

sarah.smith@immunitybio.com

{first_name}@immunitybio.com — 27.3%

sarah@immunitybio.com

{last_name}@immunitybio.com — 18.2%

smith@immunitybio.com

Key Employees

Contact details of 7 ImmunityBio executives

Patrick Soon-Shiong

Founder and Executive Chairman
  • Work email

    p*****k@immunitybio.com

Phil Rayburg

Director Facilities Management
  • Work email

    p**********g@immunitybio.com

Barry Simon

Director & Chief Corporate Affairs Officer
  • Work email

    s***n@immunitybio.com

    Verified

Sarah Singleton

Chief Communications Officer
  • Work email

    s*******n@immunitybio.com

    Verified

Helen Luu

Chief Commercial Officer
  • Work email

    h*******u@immunitybio.com

    Verified

Fabio Benedetti

Chief Strategy Officer
  • Work email

    f***o@immunitybio.com

    Verified

Enrique Diloné

Chief Technology Officer

Other Employees

Contact details of 5 ImmunityBio other employees

Richard Adcock

Job not specified
  • Work email

    r************k@immunitybio.com

Syndette Fabello

Job not specified
  • Work email

    s**************o@immunitybio.com

Hemanth Ramaprakash

Job not specified
  • Work email

    h*****************h@immunitybio.com

Dora Gruner

Senior Corporate Development Counsel
  • Work email

    d**a@immunitybio.com

    Verified

Charles Kim

General Counsel
  • Work email

    c*********m@immunitybio.com

    Verified

General Emails

General company emails, e.g. customer support lines

    info@immunitybio.com

    General Inquiries

    hello@immunitybio.com

    General Inquiries

    admin@immunitybio.com

    Admin Team

    investor@immunitybio.com

    Investor Relations

    manager@immunitybio.com

    Management Department

    kristin.regan@immunitybio.com

    Unclassified inbox

Similar Companies like ImmunityBio

HQ: North Chicago, Illinois, United States

AbbVie

abbvie.com

AbbVie is a pharmaceutical company that discovers, develops,...

HQ: North Chicago, Illinois, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Legal Name: AbbVie Inc.

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Mar 22, 2024

Founded Date: 2013

Number of Exits: 3

Company Type: For Profit

Stock Symbol: NYSE:ABBV

Operating Status: Active

HQ: Minneapolis, Minnesota, United States

Medtronic

medtronic.com

Medtronic develops healthcare technology solutions for vario...

HQ: Minneapolis, Minnesota, United States

Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics Medical Devices Hospitals & Clinics

Legal Name: Medtronic, plc.

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Mar 27, 2024

Founded Date: 1949

Number of Exits: 28

Company Type: For Profit

Stock Symbol: NYSE:MDT

Operating Status: Active

HQ: New York, New York, United States

Pfizer is a biopharmaceutical company that provides affordab...

HQ: New York, New York, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Legal Name: Pfizer Inc.

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Sep 3, 2024

Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture

Founded Date: 1849

Number of Exits: 19

Company Type: For Profit

Stock Symbol: NYSE:PFE

Operating Status: Active

Investor Type: Corporate Venture Capital, Venture Capital

Company Info

Last updated: 12/07/2025

(310) 883-1300

Culver City, California, United States

ImmunityBio General Information

Specialization: Healthcare & Medical, Health Diagnostics, Hospitals & Clinics
Legal Name: NantBioCell LLC
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Debt
Founded Date: 2014
Company Type: For Profit
Stock Symbol: NASDAQ:IBRX
Operating Status: Active
Last Funding Type: Post-IPO Debt
Phone Number: (310) 883-1300
Sub-Organization of: NantWorks
Last Investment Activity: Mar 19, 2024
Investments Activity: Mar 19, 2024 Feb 21, 2024 Jan 2, 2024

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.